Paracelsus Medical University (PMU)

Molekulare Therapie bei Genodermatosen
Research projects

Back

Investigating the potential of repurposing statins for the treatment of highly aggressive RDEB-tumors

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Globales Daten- und Patientenmanagement als Impuls für Versorgungsqualität und Forschungsinitiativen bei Epidermolysis bullosa

#Salzburg
#Research Program in Molecular Therapy of Genodermatose
#Research Program of Biomedical Data Science Salzburg

Transcriptome-guided drug repurposing for the treatment of aggressive SCCs

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Validating statins, identified by a novel in silico drug repurposing strategy, for the treatment of highly aggressive cutaneous tumors.

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Epigenetic modifiers of disease phenotypes: epidermolysis bullosa as a paradigm

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB Clinical Research 2022

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB Research 2022

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Entwicklung einer auf RNA basierenden Therapie

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Epigenetic modifiers of disease phenotypes: EB as a paradigm

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

State-of-the-art statistical design and analysis for maximal success with minimal patient burden in Epidermolysis bullosa trials

#Salzburg
#Research Management (RM) | Salzburg
#Research Program in Molecular Therapy of Genodermatose

Efficient CRISPR/Cas9n-mediated repair of a COL17A1 mutation

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

A pilot study investigating the contribution of S. aureus to the malignant transformation of RDEB keratinocytes

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB Clinical Research 2019

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB Research 2019

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Non-viral in vivo RNA therapy for dystrophic epidermolysis bullosa

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB Research 2018

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

A dual-center prospective phase II trial to establish safety, tolerability and efficacy of losartan in children with recessive dystrophic EB (RDEB)

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

"First in EB" Phase II trial of Rigosertib for RDEB SCC

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

Single stranded DNA aptamers as therapeutic molecules in recessive dystrophic epidermolysis bullosa

#Salzburg
#Research Program in Molecular Therapy of Genodermatose

EB-Research

#Salzburg
#Research Program in Molecular Therapy of Genodermatose
Back Research projects Team & Contact
Back to Overview
Paracelsus Medical University (PMU) Research & Innovation Institutes, Centers and Programs Molekulare Therapie bei Genodermatosen
Research projects